{"groups":[{"description":"Patients undergo 5 fractions of accelerated hypofractionated IMRT over 1 week with simultaneous integrated boost to gross disease. Patients then undergo pleurectomy/decortication within 14 days after completion of IMRT.\n\nHypofractionated Radiation Therapy: Undergo accelerated hypofractionated IMRT\n\nIntensity-Modulated Radiation Therapy: Undergo accelerated hypofractionated IMRT\n\nLaboratory Biomarker Analysis: Correlative studies\n\nTherapeutic Conventional Surgery: Undergo pleurectomy/decortication","id":"FG000","title":"Treatment (Hypofractionated IMRT, Pleurectomy/Decortication)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"2"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"2"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Eligibility screening by the Jonsson Comprehensive Cancer Center Data Safety Monitoring Board. Subjects undergo 5 fractions of hypofractionationated Intensity Modulated Radiation Therapy (IMRT) over 1 week with simultaneous integrated boost to gross disease.Subjects then undergo pleurectomy/decortication within 14 days after completion of IMRT.","recruitmentDetails":"From 10/2015 to 04/2018, 2 subjects were consented into the trial."}